Evidence map›Paper›PMID 26417473›Full record

ArticleJournal of addiction2015

Psychopathology in Substance Use Disorder Patients with and without Substance-Induced Psychosis.

Simon Zhornitsky, Andràs Tikàsz, Élie Rizkallah, Jean-Pierre Chiasson, Stéphane Potvin

Open access · hybridAbstract read
In one paragraph

Article in Journal of addiction, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Simon ZhornitskyDepartment of Clinical Neurosciences and Hotchkiss Brain Institute, Faculty of Medicine, University of Calgary, 2500 University Dr. NW, Calgary, AB, Canada T2N 1N4.
Andràs TikàszCentre de recherche de l'Institut Universitaire en Santé Mentale de Montréal, 7331 Hochelage Street, Montreal, QC, Canada H3P 3E5 ; Department of Psychiatry, University of Montreal, 2900 Boulevard Édouard-Montpetit, Montreal, QC, Canada H3T 1J4.
Élie RizkallahDepartment of Psychology, Université du Québec à Montréal, 100 Sherbrooke West Street, Montreal, QC, Canada H2X 3P2 ; Clinique du Nouveau Départ, 1110 Avenue Beaumont, Montreal, QC, Canada H3P 3E5.
Jean-Pierre ChiassonClinique du Nouveau Départ, 1110 Avenue Beaumont, Montreal, QC, Canada H3P 3E5.
Stéphane PotvinCentre de recherche de l'Institut Universitaire en Santé Mentale de Montréal, 7331 Hochelage Street, Montreal, QC, Canada H3P 3E5 ; Department of Psychiatry, University of Montreal, 2900 Boulevard Édouard-Montpetit, Montreal, QC, Canada H3T 1J4.
Institut Universitaire en Santé Mentale de Québec · CAUniversité du Québec à Montréal · CAUniversity of Calgary · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background. Substance-induced psychotic disorder (SIPD) is a diagnosis constructed to distinguish substance-induced psychotic states from primary psychotic disorders. A number of studies have compared SIPD persons with primary psychotic patients, but there is little data on what differentiates substance use disorder (SUD) individuals with and without SIPD. Here, we compared psychopathology, sociodemographic variables, and substance use characteristics between SUD patients with and without SIPD. Methods. A retrospective chart review was conducted on newly admitted patients at a rehabilitation centre between 2007 and 2012. Results. Of the 379 patients included in the study, 5% were diagnosed with SIPD (n = 19) and 95% were diagnosed with SUDs without SIPD (n = 360). More SIPD patients reported using cannabis and psychostimulants, and fewer SIPD patients reported using alcohol than SUDs patients without SIPD. SIPD patients scored higher on the "schizophrenia nuclear symptoms" dimension of the SCL-90R psychoticism scale and exhibited more ClusterB personality traits than SUD patients without SIPD. Discussion. These data are consistent with previous studies suggesting that psychopathology, substance type, and sociodemographic variables play important role in the development of SIPD. More importantly, the results highlight the need for paying greater attention to the types of self-reported psychotic symptoms during the assessment of psychotomimetic effects associated with psychoactive substances.

Identifiers

PMID26417473
PMCPMC4568375
OpenAlexW1637788425

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.